BPM Pro 2 integrates and automates many aspects of clinical workflows. It has FDA clearance to measure blood pressure and pulse rate in adults with arm circumferences of 9-17 inches or 16-20 inches. The company says it empowers care teams to scale remote patient monitoring and streamline operations.
The system allows patients to take more reliable at-home blood pressure measurements under optimal conditions. It collects highly precise measurements while introducing a new Patient Insights feature that enriches data with context from users’ daily lives.
Patient Insights asks about symptoms, medication adherence and more. This enables a more comprehensive understanding of each reading while reducing clinical workloads. It also automates key tasks for care teams to help combine real-time data capture with actionable insights.
Automating processes like symptom tracking, measurement prompts and reminders reduces the need for manual patient outreach. Withings says this allows healthcare providers to focus more on delivering quality care. Additional key features include personalized health nudges, an accessible design and seamless connectivity.
“We are thrilled BPM Pro 2 is now FDA-cleared, this device marks a significant advancement in remote patient monitoring. BPM Pro 2 not only delivers precise, clinically meaningful blood pressure and pulse rate measurements but also empowers care teams with real-time insights and direct patient engagement tools,” said Antoine Robiliard, VP of Withings Health Solutions. “This milestone, along with the recognition as a CES 2025 Innovation Awards Honoree, underscores our commitment to creating solutions that streamline workflows, enhance patient involvement, and set new standards for the quality and reliability of remote care.”
